🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparative Effect of Instrument-Assisted Soft Tissue Mobilization and Deep Transverse Friction Massage in Patients With Trapezius Myalgia

RecruitingNAAges 18 Years - 45 YearsAllIbadat International University, Islamabad
NCT07820293 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized controlled trial compares the effectiveness of Instrument-Assisted Soft Tissue Mobilization (IASTM) and Deep Transverse Friction Massage (DTFM) in patients with trapezius myalgia. A total of 42 participants aged 18-45 years will be randomly assigned to either intervention group. Both groups will also receive conventional physiotherapy consisting of TENS, hot packs, range-of-motion exercises, and stretching. Treatment will be provided four sessions per week for four weeks. Outcomes include pain intensity, cervical range of motion, muscle strength, and functional disability.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Male and female participants aged 18-45 years. Clinical diagnosis of trapezius myalgia with neck pain lasting more than two weeks. Tenderness over the upper trapezius muscle. NPRS pain score greater than 4. Cervical flexion less than 60° and extension less than 50°. Able to understand the study procedures and provide written informed consent. Exclusion Criteria: * Congenital or structural musculoskeletal deformities (e.g., torticollis, scoliosis, cervical rib). Open wounds, skin infections, or dermatological conditions over the treatment area. Cervical spine or upper limb surgery within the previous 12 months. Cervical radiculopathy, cervical spondylosis, herniated disc, or whiplash injury.
💊

What it tests

  • Deep Transverse Friction Massage (DTFM)
  • Instrument-Assisted Soft Tissue Mobilization (IASTM)
📍

Where

1 site
Ibadat International University, Islamabad (Iiui)
Islamabad, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy